當前位置：首頁 JCRQ2 期刊介紹(非官網)

Neuro-oncology PracticeSCIE

國際簡稱：NEURO-ONCOL PRACT 參考譯名：神經腫瘤學實踐

CiteScore分區
Q2
JCR分區
Q2

基本信息：: ISSN：2054-2577; E-ISSN：2054-2585; 是否OA：未開放; 是否預警：否

出版信息：: 出版商：Oxford University Press; 出版語言：English; 研究方向：CLINICAL NEUROLOGY

評價信息：: 影響因子：2.4; CiteScore指數：5.3; SJR指數：0.81; SNIP指數：0.91

發文數據：: Gold OA文章占比：27.92%; 研究類文章占比：92.45%; 年發文量：53

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據 JCR分區發文數據常見問題

英文簡介Neuro-oncology Practice期刊介紹

Neuro Oncology Practice is an internationally peer-reviewed journal dedicated to the field of neurooncology. Its aim is to provide a platform for clinical doctors, researchers, and other healthcare professionals to exchange the latest clinical practices, treatment strategies, research findings, and patient care experiences. This magazine emphasizes practicality and education, covering the diagnosis, treatment, prognosis evaluation, and related basic scientific research of brain tumors.

The magazine is dedicated to promoting research and education in the field of neuroblastoma. The editorial committee of this journal is composed of renowned neurooncologists from around the world, ensuring that the published content has high academic standards and clinical relevance. The content of the magazine includes not only original research articles, clinical trial reports, case reports, and reviews, but also educational columns, conference abstracts, and invited comments aimed at helping readers understand the latest developments and best practices in the field of neurooncology. It supports healthcare professionals in making wiser decisions in daily practice and improving patient treatment outcomes by providing timely information and in-depth analysis.

期刊簡介Neuro-oncology Practice期刊介紹

《Neuro-oncology Practice》該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：
SCIE
非預警

Cite Score數據（2024年最新版）Neuro-oncology Practice Cite Score數據

CiteScore：5.3
SJR：0.806
SNIP：0.908

學科類別	分區	排名	百分位
大類：Medicine 小類：Medicine (miscellaneous)	Q2	101 / 398	74%
大類：Medicine 小類：Neurology	Q2	71 / 192	63%
大類：Medicine 小類：Oncology	Q2	156 / 404	61%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

JCR分區Neuro-oncology Practice JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：CLINICAL NEUROLOGY	ESCI	Q2	137 / 277	50.7%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：CLINICAL NEUROLOGY	ESCI	Q2	128 / 278	54.14%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

本刊中國學者近年發表論文

1、Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period
Author: Woo, Peter Y. M.; Yau, Stephen; Lam, Tai-Chung; Pu, Jenny K. S.; Li, Lai-Fung; Lui, Louisa C. Y.; Chan, Danny T. M.; Loong, Herbert H. F.; Lee, Michael W. Y.; Yeung, Rebecca; Kwok, Carol C. H.; Au, Siu-Kie; Tan, Tze-Ching; Kan, Amanda N. C.; Chan, Tony K. T.; Mak, Calvin H. K.; Mak, Henry K. F.; Ho, Jason M. K.; Cheung, Ka-Man; Tse, Teresa P. K.; Lau, Sarah S. N.; Chow, Joyce S. W.; El-Helali, Aya; Ng, Ho-Keung; Poon, Wai-Sang

Journal: NEURO-ONCOLOGY PRACTICE. 2023; Vol. 10, Issue 1, pp. 50-61. DOI: 10.1093/nop/npac069
2、Valproic acid as a radio-sensitizer in glioma: A systematic review and meta-analysis
Author: Sullivan, Jessica K.; Fahey, Paul P.; Agho, Kinglsey E.; Hurley, Simon P.; Feng, Zhihui; Day, Richard O.; Lim, David

Journal: NEURO-ONCOLOGY PRACTICE. 2023; Vol. 10, Issue 1, pp. 13-23. DOI: 10.1093/nop/npac078

投稿常見問題

<s id="cww8k"></s>